Sarepta Therapeutics (SRPT) August weekly volatility decreases into recently delayed FDA decision

August 22, 2016 11:11 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Sarepta Therapeutics (NASDAQ: SRPT) August weekly call option implied volatility is at 119, September is at 214, November is at 209; compared to its 52-week range of 67 to 399 into recently delayed FDA decision regarding eteplirsen.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment